Monday, June 23, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

MediWound raises $30m for clinical trial, production expansion

by Gali Weinreb
September 23, 2022
in Business
Reading Time: 2 mins read
A A
0
Home Business
Share on FacebookShare on Twitter

Israeli biopharmaceutical company MediWound Ltd. (Nasdaq: MDWD), which has developed and sells a preparation for treating for burns that is undergoing clinical trials for treating wounds, has announced that it has raised $30 million. The fundraise was at market price. Among the investors are New Era Capital Partners, Deep Insight, IBF, and Discount Capital.

Over the past year, MediWound’s share price has fallen 51%, in line with a decline in the biomed sector in general. The company has a current market cap of $58 million. Clal Biotechnology Industries (TASE: CBI) holds 33% of the company, and has a market cap of NIS 133 million.

MediWound extracts from the stem of the pineapple plant a substance (bromelain) that can remove burned skin without harming healthy tissue. This process is currently a surgical procedure. The company’s product for treating burns has been sol din the European market for about a decade. The market for burns treatments for adults in Europe is fairly small, and in the first quarter the company had revenue of $4.7 million.

MediWound is taking steps to increase its market, both in the burns category and through expansion into an additional field, treating wounds. In burns, it awaits marketing approval in the US, Japan, and India, and also for extension of the existing indication for the product to burns in children, who represent 30% of the burns treatment market.

In wounds, the company is in the process of a Phase II trial in the US. The proceeds of its fundraise will be used to finance a Phase III clinical trial and to expand the company’s production facility.

Ofer Gonen, who was CEO of Clal Biotechnology, was recently appointed CEO of MediWound. Following the announcement of the fundraise, Gonen said, “We are making progress towards achieving our strategic goals, and we now have the cash to support all the company’s channels of activity: we are expanding our production capacity to support sales of NexoBrid (the burns product) around the world, and we shall be able to finance the continued development of EscharEX (the wounds treatment) independently.”

MediWound has said in the past that the good results of the Phase II trial of its wound treatment had aroused interest on the part of several strategic players. It is best, however, to approach such a deal from a strong financial position, and the company now has $40 million cash.

Published by Globes, Israel business news – en.globes.co.il – on September 22, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.




Source link

Tags: 30MClinicalExpansionMediWoundproductionraisesTrial
Previous Post

Ford India revises final severance package to employees. Here’s how much it will pay  

Next Post

central bank of india: Out of PCA, Central Bank aims for below 10% NPA in three months

Related Posts

First Trade: Nifty slips 150 points to trade at 24,961; IT gauge top loser

First Trade: Nifty slips 150 points to trade at 24,961; IT gauge top loser

by zee business
June 23, 2025
0

Indian inventory market at present: Indian equities in Monday's commerce opened decrease amid escalating tensions between Iran and Israel after the...

War Will Erupt In Middle East If Iran Blocks Strait Of Hormuz, Says Narendra Taneja

War Will Erupt In Middle East If Iran Blocks Strait Of Hormuz, Says Narendra Taneja

by Ananya Chaudhuri
June 22, 2025
0

In case Iran turns into profitable in blocking the Strait of Hormuz, there will likely be a full-blown struggle within...

Chopper crashes must lead up to better regulation

Chopper crashes must lead up to better regulation

by Euro Times
June 22, 2025
0

Non secular tourism should be accompanied by extra accountable governance, each within the air and on the bottom | Photograph...

Israeli startup Lembas unveils food additive for slimming

Israeli startup Lembas unveils food additive for slimming

by Gali Weinreb
June 23, 2025
0

Israeli foodtech startup Lembas has emerged from stealth and reported that it has developed GLP-1 Edge, a bioactive peptide...

Ahead of Market: 10 things that will decide stock market action on Monday

Ahead of Market: 10 things that will decide stock market action on Monday

by Riya Sharma
June 22, 2025
0

The Indian market ended within the inexperienced on Friday, snapping a three-day shedding streak, as a rally in monetary shares...

US steps into war between Israel and Iran, strikes 3 Iranian nuclear sites

US steps into war between Israel and Iran, strikes 3 Iranian nuclear sites

by zee business
June 22, 2025
0

The US army struck three websites in Iran early Sunday, inserting itself into Israel ’s conflict aimed toward destroying the...

Next Post
central bank of india: Out of PCA, Central Bank aims for below 10% NPA in three months

central bank of india: Out of PCA, Central Bank aims for below 10% NPA in three months

Morningstar Investor Review

Morningstar Investor Review

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Last Chance to Buy Solaxy at Presale Price: 5 Hours Left

Last Chance to Buy Solaxy at Presale Price: 5 Hours Left

June 23, 2025
Ares Alternative Credit To Buy 20% Stake In Eni Plenitude

Ares Alternative Credit To Buy 20% Stake In Eni Plenitude

June 23, 2025
First Trade: Nifty slips 150 points to trade at 24,961; IT gauge top loser

First Trade: Nifty slips 150 points to trade at 24,961; IT gauge top loser

June 23, 2025
The Best Space Stock Out There Is…

The Best Space Stock Out There Is…

June 23, 2025
Air India crash risks fueling up to 30% jump in insurance premiums

Air India crash risks fueling up to 30% jump in insurance premiums

June 23, 2025
One in seven people ‘have lost money to fraud in past year’

One in seven people ‘have lost money to fraud in past year’

June 23, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Last Chance to Buy Solaxy at Presale Price: 5 Hours Left

Ares Alternative Credit To Buy 20% Stake In Eni Plenitude

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In